drugset
drugset / Trial / NCT01364922

Phase 2 Chronic Low Back Pain Study

NCT01364922 ↗

Phase 2 Completed 168 enrolled AbbVie
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary purpose of this study was to evaluate the analgesic effect and safety of hydrocodone/acetaminophen extended release compared to placebo.

Timeline

Start
2011-06
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrocodone Unknown — —

Indications

chronic pain syndrome